Home / Investors Information / EDAP Schedules Webcast and Conference Call for Second Quarter 2013 Results Read more about EDAP Schedules Webcast and Conference Call for Second Quarter 2013 Results EDAP Granted European Market Clearance for Focal.One(R) Read more about EDAP Granted European Market Clearance for Focal.One(R) EDAP Fully Redeems $8.0 Million Long-Term Debt Read more about EDAP Fully Redeems $8.0 Million Long-Term Debt EDAP Significantly Strengthens Financial Profile Read more about EDAP Significantly Strengthens Financial Profile EDAP to Raise $12 Million in Registered Direct Offering Read more about EDAP to Raise $12 Million in Registered Direct Offering EDAP's Ablatherm-HIFU Demonstrates Long Term Efficacy, Durability and Reproducibility With Prospective Fourteen -Year Study Read more about EDAP's Ablatherm-HIFU Demonstrates Long Term Efficacy, Durability and Reproducibility With Prospective Fourteen -Year Study EDAP Reports 23% Increase in First Quarter 2013 Revenues Read more about EDAP Reports 23% Increase in First Quarter 2013 Revenues EDAP's Ablatherm-HIFU Receives Two Best Poster Awards at 2013 American Urological Association Annual Meeting Read more about EDAP's Ablatherm-HIFU Receives Two Best Poster Awards at 2013 American Urological Association Annual Meeting EDAP Schedules Webcast and Conference Call for First Quarter 2013 Results Read more about EDAP Schedules Webcast and Conference Call for First Quarter 2013 Results EDAP Outlines Significant Participation at 2013 American Urological Association Annual Meeting Read more about EDAP Outlines Significant Participation at 2013 American Urological Association Annual Meeting Pagination First page « First Previous page ‹ Previous … Page 26 Page 27 Page 28 Page 29 Current page 30 Page 31 Page 32 Page 33 Page 34 … Next page Next › Last page Last » Subscribe to
EDAP Schedules Webcast and Conference Call for Second Quarter 2013 Results Read more about EDAP Schedules Webcast and Conference Call for Second Quarter 2013 Results
EDAP Granted European Market Clearance for Focal.One(R) Read more about EDAP Granted European Market Clearance for Focal.One(R)
EDAP Fully Redeems $8.0 Million Long-Term Debt Read more about EDAP Fully Redeems $8.0 Million Long-Term Debt
EDAP Significantly Strengthens Financial Profile Read more about EDAP Significantly Strengthens Financial Profile
EDAP to Raise $12 Million in Registered Direct Offering Read more about EDAP to Raise $12 Million in Registered Direct Offering
EDAP's Ablatherm-HIFU Demonstrates Long Term Efficacy, Durability and Reproducibility With Prospective Fourteen -Year Study Read more about EDAP's Ablatherm-HIFU Demonstrates Long Term Efficacy, Durability and Reproducibility With Prospective Fourteen -Year Study
EDAP Reports 23% Increase in First Quarter 2013 Revenues Read more about EDAP Reports 23% Increase in First Quarter 2013 Revenues
EDAP's Ablatherm-HIFU Receives Two Best Poster Awards at 2013 American Urological Association Annual Meeting Read more about EDAP's Ablatherm-HIFU Receives Two Best Poster Awards at 2013 American Urological Association Annual Meeting
EDAP Schedules Webcast and Conference Call for First Quarter 2013 Results Read more about EDAP Schedules Webcast and Conference Call for First Quarter 2013 Results
EDAP Outlines Significant Participation at 2013 American Urological Association Annual Meeting Read more about EDAP Outlines Significant Participation at 2013 American Urological Association Annual Meeting
